InSyBio qualifies to InnoSTARS semifinal and travels to China to compete for Chinese investments and strategic partners

InSyBio has been nominated as semi-finalist in the 2017 InnoSTARS Competition and will soon be traveling to China for the semi-final phase. InSyBio will be pitching to prominent Chinese investors with a chance to receive funding, strategic partners and exposure to one of the most coveted markets in the world.

InSyBio, which has qualified in the Biotechnology and Healthcare category, is an innovative global bioinformatics company focusing, through advanced biological big-data computational tools, on biomarkers discovery for Cancer, Neurodegenerative diseases and Nutrition, addressing the ever increasing needs for drug discovery and research acceleration in Pharmaceutical and Nutrition Organizations.

To read the full story click here.